Search filters

List of works by Jennifer R Diamond

A Phase I Dose-Escalation Study of Linsitinib (OSI-906), a Small-Molecule Dual Insulin-Like Growth Factor-1 Receptor/Insulin Receptor Kinase Inhibitor, in Combination with Irinotecan in Patients with Advanced Cancer.

scientific article published on 23 August 2018

A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer

scientific article published on 02 August 2018

Clinical outcomes of breast cancer patients treated in phase I clinical trials at University of Colorado Cancer Center

scientific article published on 16 October 2020

From bench to bedside: lessons learned in translating preclinical studies in cancer drug development

scientific article (publication date: 2 October 2013)

Initial Clinical Sensitivity and Acquired Resistance to MET Inhibition in MET-Mutated Papillary Renal Cell Carcinoma ⬇️

scientific article published on April 22, 2013

Medullary Thyroid Cancer and Pseudocirrhosis: Case Report and Literature Review ⬇️

scientific article published on February 1, 2012

Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of ENMD-2076, a Novel Angiogenic and Aurora Kinase Inhibitor,in Patients with Advanced Solid Tumors ⬇️

scientific article published on 03 December 2010

Phase I study of oral rigosertib (ON 01910.Na), a dual inhibitor of the PI3K and Plk1 pathways, in adult patients with advanced solid malignancies

scientific article

Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer

scientific article published on 14 August 2020

Paulina is supported by:

About Paulina

Help